Literature DB >> 9231795

Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro.

A Sato1, J P Liu, J W Funder.   

Abstract

Aldosterone lowers protein kinase C (PKC) activity in myocyte-enriched cultures from neonatal Sprague-Dawley rat hearts, with activity measured by the transfer of phosphate to myristolated alanine-rich C-kinase substrate, in the presence of Ca2+, phosphatidylserine, and diolein. The effect is rapid, with a significant effect after 1 min exposure, half maximal at < or = 1 nM aldosterone, with steroids showing a hierarchy of potency aldosterone = 9alpha fluorocortisol > deoxycorticosterone > corticosterone > spironolactone. Both Ca2+-dependent and -independent PKC activity appear equally inhibited by aldosterone, and PMA-stimulated increases in PKC activity appear similarly aldosterone-sensitive. No displaceable binding of [3H]aldosterone to purified PKC can be shown, evidence against a direct effect of aldosterone on PKC; aldosterone does not alter basal or PMA-stimulated PKC activity in cardiac fibroblasts, evidence for a cell-specific mediator of the myocyte effect. Taken with the previous demonstration of the potentiation of aldosterone-specific MR-mediated effects by PKC activation, the present data argue for the existence of a complex cross-talk mechanism between aldosterone and factors affecting PKC activity in the heart.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231795     DOI: 10.1210/endo.138.8.5352

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes.

Authors:  Martin Wehling
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

Review 2.  Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones.

Authors:  P J Davis; H C Tillmann; F B Davis; M Wehling
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

Review 3.  Aldosterone receptor blockade in the management of heart failure.

Authors:  Emiliano A Palmieri; Bernadette Biondi; Serafino Fazio
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 4.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

5.  Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.

Authors:  Natalia Tsybouleva; Lianfeng Zhang; Suetnee Chen; Rajnikant Patel; Silvia Lutucuta; Shintaro Nemoto; Gilberto DeFreitas; Mark Entman; Blase A Carabello; Robert Roberts; A J Marian
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

6.  Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor.

Authors:  Eric E Essick; Flora Sam
Journal:  Int J Hypertens       Date:  2011-05-22       Impact factor: 2.420

7.  The Effects of Salt and Glucose Intake on Angiotensin II and Aldosterone in Obese and Nonobese Patients with Essential Hypertension.

Authors:  Nouralsalhin Alaagib; Mohammed Sukkar; Mohammed Kardash
Journal:  Int J Hypertens       Date:  2020-03-19       Impact factor: 2.420

Review 8.  Why are mineralocorticoid receptor antagonists cardioprotective?

Authors:  Wenxia Chai; A H Jan Danser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-31       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.